Diagnosis, prognosis, and monitoring of hematopoietic neoplasms. This test is intended for oncology studies on peripheral blood, usually when bone marrow is not available for testing. For chromosome analysis to evaluate for a constitutional/congenital finding, order Chromosome Analysis, Constitutional Peripheral Blood (2002289).
New York DOH Approval Status
Green (sodium heparin).
Transport 5 mL whole blood. (Min: 0.5 mL)
Frozen specimens. Clotted specimens.
Ambient: 48 hours; Refrigerated: 48 hours; Frozen: Unacceptable
Refer to report
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
These studies involve culturing of living cells; therefore, turnaround times given represent average times, which are subject to multiple variables.
A processing fee will be charged if this procedure is canceled at the client's request after the test has been set up or if the specimen integrity is inadequate to allow culture growth.
This test must be ordered using Oncology test request form (#43099) or through your ARUP interface.
|Component Test Code*||Component Chart Name||LOINC|
|0097635||Chromosome Analysis, Leukemic Blood||62357-9|
|2002204||EER Chromosome Analysis, Leukemic Blood||11526-1|
- Chromosome analysis, Leukemia/Lymphoma
- Hematologic Chromosome Analysis
- leukemic blood chromosome
- Leukemic blood karyotype
- Neoplastic peripheral blood